ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
The Column Group (TCG)
Scientist II, Cell Line Engineering and CRISPR Screening at Eikon Therapeutics supports drug discovery by developing and validating engineered mammalian cell models and performing CRISPR-based functional genomics screens. The role contributes to target validation and integrates experimental and computational analyses to accelerate therapeutic discovery.
The Column Group (TCG) is a venture ecosystem dedicated to fueling scientific innovation in the life sciences industry. Through Platform funds, Opportunity funds, TCG Labs-Soleil, and TCGX, it supports early-stage biotech ventures from formation through exit, providing capital and strategic guidance to advance therapeutic and biotech technologies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for The Column Group (TCG).
Postdoctoral position in single-cell functional genomics, Norman Lab
Memorial Sloan Kettering Cancer Center
Associate Principal Scientist, Systems Biology
MSD
Senior Scientist I, Cell Therapy Discovery
AstraZeneca
Senior Scientist, Functional Genomics, High-Throughput Screening
Amgen
Senior Scientist II, Cell Therapy Discovery
AstraZeneca
Research Associate, Automation & Screening (6 Month Contract)
Monte Rosa Therapeutics, Inc